期刊文献+

阿托伐他汀钙联合非诺贝特治疗糖尿病合并高血脂患者的疗效观察 被引量:1

Curative effect observation of atorvastatin calcium combined with fenofibrate in the treatment of patients with diabetes complicated with hyperlipidemia
下载PDF
导出
摘要 目的:探讨阿托伐他汀钙联合非诺贝特治疗糖尿病合并高血脂患者的疗效。方法:收治糖尿病合并高血脂的患者58例,平分为两组。他汀治疗组给予阿托伐他汀钙治疗,联合治疗组给予阿托伐他汀联合非诺贝特治疗,观察疗效。结果:治疗12周后,联合治疗组TG、LDL-C、TC值均低于他汀治疗组;联合治疗组TG、HDL-C、LDL-C的达标率均高于他汀治疗组,差异具有统计学意义(P<0.05)。结论:阿托伐他汀钙联合非诺贝特治疗糖尿病合并高血脂疗效显著。 Objective:To investigate the effect of atorvastatin calcium combined with fenofibrate in the treatment of patients withdiabetes complicated with hyperlipidemia.Methods:58 patients with diabetes complicated with hyperlipidemia were selected.Theywere divided into the two groups on average.The statin therapy group were treated by atorvastatin,while the combined treatmentgroup received atorvastatin calcium combined with fenofibrate treatment.We observed the curative effect.Results:After 12 weeksof treatment,the values of TG,LDL-C and TC in the combination therapy group were lower than those in the statin group;thecompliance rates of TG,HDL-C and LDL-C in the combined treatment group were higher than those in the statin group;thedifferences were statistically significant(P<0.05).Conclusion:The effect of atorvastatin calcium combined with fenofibrate in thetreatment of patients with diabetes complicated with hyperlipidemia is significant.
作者 余波 Yu Bo(Jinyinhu Street Hospital of Dongxi Hu District,Wuhan City 430023)
出处 《中国社区医师》 2016年第16期36-37,共2页 Chinese Community Doctors
关键词 阿托伐他汀钙 非诺贝特 糖尿病 高血脂 Atorvastatin calcium Fenofibrate Diabetes hyperlipidemia
  • 相关文献

参考文献6

二级参考文献59

  • 1李艳波,邓华聪,郑丹,李呼伦.P38信号通路对人脐静脉内皮细胞单核细胞趋化蛋白-1表达的影响[J].中华糖尿病杂志(1006-6187),2004,12(4):287-289. 被引量:8
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 3Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cho- lesterol - lowering treatment: prospective meta - analysis of data from 90056 participants in 14 randomised trials of statins [ J ]. Lancet, 2005, 366 (9493) : 1267 -1278.
  • 4Kearney PM, Blaekwell L, Collins R, et al. Efficacy of cholesterol -lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis [J]. Laneet, 2008, 371 (9607) : 117 - 125.
  • 5Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C - reactive protein [J]. NEnglJMed, 2008, 359 (21): 2195-2207.
  • 6LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J]. N Engl J Med, 2005, 352 (14): 1425-1435.
  • 7Pedersen TR, Faergeman O, Kastelein JJ, et al. High - dose atorvas- tatin vs usual - dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial [ J ]. JA- MA, 2005, 294 (19) : 2437 - 2445.
  • 8Yusuf S, Lonn E, Bosch J, et al. Lipid lowering for primary preven- tion [J]. Lancet, 2009, 373 (9670): 1152-1155.
  • 9Colbert JD, Stone JA. Statin use and the risk of ineident diabetes melli- tus: a review of the literature [J]. Can J Cardiol, 2012, 28 (5): 581 -589.
  • 10Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive - dose compared with moderate - dose statin therapy : a meta - analysis [J]. JAMA, 2011, 305 (24): 2556-2564.

共引文献82

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部